Line |
Label |
Object Class |
Period Type |
Balance |
Report ElementName |
1 |
00090 - Document - Document and Entity Information |
Network |
* |
* |
http://www.redhillbio.com/role/DocumentDocumentAndEntityInformation |
2 |
Implied Table |
Table |
* |
* |
implied:Table |
3 |
Document and Entity Information [Abstract] |
Abstract |
|
|
rdhl:DocumentAndEntityInformationAbstract |
4 |
Entity Registrant Name |
Concept (Text/String) |
For Period |
|
dei:EntityRegistrantName |
5 |
Entity Central Index Key |
Concept (CIK Number) |
For Period |
|
dei:EntityCentralIndexKey |
6 |
Document Type |
Concept (Submission Type) |
For Period |
|
dei:DocumentType |
7 |
Document Period End Date |
Concept (Date) |
For Period |
|
dei:DocumentPeriodEndDate |
8 |
Amendment Flag |
Concept (Yes/No) |
For Period |
|
dei:AmendmentFlag |
9 |
Current Fiscal Year End Date |
Concept (Month/Day) |
For Period |
|
dei:CurrentFiscalYearEndDate |
10 |
Entity Well-known Seasoned Issuer |
Concept (Yes/No) |
For Period |
|
dei:EntityWellKnownSeasonedIssuer |
11 |
Entity Voluntary Filers |
Concept (Yes/No) |
For Period |
|
dei:EntityVoluntaryFilers |
12 |
Entity Current Reporting Status |
Concept (Yes/No) |
For Period |
|
dei:EntityCurrentReportingStatus |
13 |
Entity Filer Category |
Concept (Filer Category) |
For Period |
|
dei:EntityFilerCategory |
14 |
Entity Common Stock, Shares Outstanding |
Concept (Shares) |
As Of |
|
dei:EntityCommonStockSharesOutstanding |
15 |
Entity Emerging Growth Company |
Concept (Yes/No) |
For Period |
|
dei:EntityEmergingGrowthCompany |
16 |
Entity Shell Company |
Concept (Yes/No) |
For Period |
|
dei:EntityShellCompany |
17 |
Document Fiscal Year Focus |
Concept (Year) |
For Period |
|
dei:DocumentFiscalYearFocus |
18 |
Document Fiscal Period Focus |
Concept (Fiscal Period) |
For Period |
|
dei:DocumentFiscalPeriodFocus |
19 |
00100 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
Network |
* |
* |
http://www.redhillbio.com/role/StatementConsolidatedStatementsOfComprehensiveLoss |
20 |
Implied Table |
Table |
* |
* |
implied:Table |
21 |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS |
Abstract |
|
|
ifrs-full:IncomeStatementAbstract |
22 |
NET REVENUES |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
23 |
COST OF REVENUES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
24 |
GROSS PROFIT |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
25 |
RESEARCH AND DEVELOPMENT EXPENSES, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
26 |
SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SalesAndMarketingExpense |
27 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
28 |
OTHER EXPENSES |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherOperatingIncomeExpense |
29 |
OPERATING LOSS |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
30 |
FINANCIAL INCOME |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
31 |
FINANCIAL EXPENSES |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
32 |
FINANCIAL INCOME, net |
Concept (Monetary) |
For Period |
Credit |
rdhl:FinanceIncomeCostsNet |
33 |
LOSS AND COMPREHENSIVE LOSS FOR THE PERIOD |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
34 |
LOSS PER ORDINARY SHARE (U.S. dollars): |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
35 |
Basic (in dollars per share) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
36 |
Diluted (U.S. dollars) |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
37 |
WEIGHTED AVERAGE OF ORDINARY SHARES (in thousands) |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
38 |
00200 - Statement - CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
Network |
* |
* |
http://www.redhillbio.com/role/StatementConsolidatedStatementsOfFinancialPosition |
39 |
Implied Table |
Table |
* |
* |
implied:Table |
40 |
CONSOLIDATED STATEMENTS OF FINANCIAL POSITION |
Abstract |
|
|
ifrs-full:StatementOfFinancialPositionAbstract |
41 |
CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:CurrentAssetsAbstract |
42 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
43 |
Bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:BalancesWithBanks |
44 |
Financial assets at fair value through profit or loss |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss |
45 |
Trade receivables |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:TradeAndOtherCurrentReceivables |
46 |
Prepaid expenses and other receivables |
Concept (Monetary) |
As Of |
Debit |
rdhl:CurrentPrepaidExpensesAndReceivables |
47 |
Inventory |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
48 |
Total current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAssets |
49 |
NON-CURRENT ASSETS: |
Abstract |
|
|
ifrs-full:NoncurrentAssetsAbstract |
50 |
Bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:LongtermDeposits |
51 |
Fixed assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
52 |
Intangible assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
53 |
Total non-current assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:NoncurrentAssets |
54 |
TOTAL ASSETS |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Assets |
55 |
LIABILITIES |
Abstract |
|
|
ifrs-full:LiabilitiesAbstract |
56 |
CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
57 |
Accounts payable |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:TradeAndOtherCurrentPayables |
58 |
Accrued expenses and other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities |
59 |
Payable in respect of intangible asset purchase |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentPayablesForPurchaseOfNoncurrentAssets |
60 |
Total current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentLiabilities |
61 |
NON-CURRENT LIABILITIES: |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
62 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentDerivativeFinancialLiabilities |
63 |
Royalty obligation |
Concept (Monetary) |
As Of |
Credit |
rdhl:NoncurrentRoyaltyObligation |
64 |
Total non-current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:NoncurrentLiabilities |
65 |
TOTAL LIABILITIES |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Liabilities |
66 |
EQUITY: |
Abstract |
|
|
ifrs-full:EquityAbstract |
67 |
Ordinary shares |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:IssuedCapital |
68 |
Additional paid-in capital |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:SharePremium |
69 |
Accumulated deficit |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:RetainedEarnings |
70 |
TOTAL EQUITY |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
71 |
TOTAL LIABILITIES AND EQUITY |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:EquityAndLiabilities |
72 |
00300 - Statement - CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY |
Network |
* |
* |
http://www.redhillbio.com/role/StatementConsolidatedStatementsOfChangesInEquity |
73 |
Statement of changes in equity [table] |
Table |
* |
* |
ifrs-full:StatementOfChangesInEquityTable |
74 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
75 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
76 |
Ordinary shares |
Member |
|
|
ifrs-full:IssuedCapitalMember |
77 |
Additional paid-in capital |
Member |
|
|
ifrs-full:SharePremiumMember |
78 |
Warrants |
Member |
|
|
rdhl:WarrantsMember |
79 |
Accumulated deficit |
Member |
|
|
ifrs-full:RetainedEarningsMember |
80 |
Statement of changes in equity |
LineItems |
|
|
ifrs-full:StatementOfChangesInEquityLineItems |
81 |
Balance at beginning of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
82 |
Share-based compensation to employees and service providers |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions |
83 |
Issuance of ordinary shares, net of expenses |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IssueOfEquity |
84 |
Exercise of warrants and options into ordinary shares |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughExerciseOfOptions |
85 |
Warrants expiration |
Concept (Monetary) |
For Period |
Credit |
rdhl:IncreaseDecreaseThroughWarrantsExpiration |
86 |
Comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
87 |
Balance at end of period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:Equity |
88 |
00400 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS |
Network |
* |
* |
http://www.redhillbio.com/role/StatementConsolidatedStatementsOfCashFlows |
89 |
Implied Table |
Table |
* |
* |
implied:Table |
90 |
CONSOLIDATED STATEMENTS OF CASH FLOWS |
Abstract |
|
|
ifrs-full:StatementOfCashFlowsAbstract |
91 |
OPERATING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInOperatingActivitiesAbstract |
92 |
Comprehensive loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLoss |
93 |
Adjustments in respect of income and expenses not involving cash flow: |
Abstract |
|
|
ifrs-full:AdjustmentsForReconcileProfitLossAbstract |
94 |
Share-based compensation to employees and service providers |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForSharebasedPayments |
95 |
Depreciation |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDepreciationExpense |
96 |
Write-off of intangible assets |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLoss |
97 |
Fair value adjustment on derivative financial instruments |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:AdjustmentsForGainsLossesOnChangeInFairValueOfDerivatives |
98 |
Fair value losses (gains) on financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss |
99 |
Revaluation of bank deposits |
Concept (Monetary) |
For Period |
Credit |
rdhl:AdjustmentsForRevaluationOfBankDeposits |
100 |
Issuance cost in respect of warrants |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForFinanceCosts |
101 |
Exchange differences in respect of cash and cash equivalents |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains |
102 |
Total adjustments in respect of income and expenses not involving cash flow |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsToReconcileProfitLossOtherThanChangesInWorkingCapital |
103 |
Changes in assets and liability items: |
Abstract |
|
|
rdhl:ChangesInAssetsAndLiabilityItemsAbstract |
104 |
Decrease (increase) in trade receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable |
105 |
Decrease (increase) in prepaid expenses and other receivables |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables |
106 |
Decrease (increase) in inventory |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForDecreaseIncreaseInInventories |
107 |
Increase (decrease) in accounts payable |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable |
108 |
Increase (decrease) in accrued expenses and other current liabilities |
Concept (Monetary) |
For Period |
Debit |
rdhl:AdjustmentsForDecreaseIncreaseInAccruedExpenses |
109 |
Total changes in assets and liability items |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseInWorkingCapital |
110 |
Net cash used in operating activities |
Concept (Monetary) |
For Period |
|
ifrs-full:CashFlowsFromUsedInOperatingActivities |
111 |
INVESTING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInInvestingActivitiesAbstract |
112 |
Purchase of fixed assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities |
113 |
Purchase of intangible assets |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities |
114 |
Change in investment in current bank deposits |
Concept (Monetary) |
For Period |
Credit |
rdhl:AdjustmentsForChangeInInvestmentInCurrentBankDepositsClassifiedAsInvestingActivities |
115 |
Purchase of financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities |
116 |
Proceeds from sale of financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromSalesOrMaturityOfFinancialInstrumentsClassifiedAsInvestingActivities |
117 |
Net cash provided by (used in) investing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInInvestingActivities |
118 |
FINANCING ACTIVITIES: |
Abstract |
|
|
ifrs-full:CashFlowsFromUsedInFinancingActivitiesAbstract |
119 |
Proceeds from issuance of ordinary shares, net of expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
120 |
Exercise of warrants and options into ordinary shares, net of expenses |
Concept (Monetary) |
For Period |
Debit |
rdhl:ProceedsFromExerciseOfWarrantsAndOptions |
121 |
Repayment of payable in respect of intangible asset purchase |
Concept (Monetary) |
For Period |
Credit |
rdhl:RepaymentOfPayableInRespectOfIntangibleAssetPurchase |
122 |
Net cash provided by financing activities |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CashFlowsFromUsedInFinancingActivities |
123 |
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges |
124 |
EXCHANGE DIFFERENCES ON CASH AND CASH EQUIVALENTS |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents |
125 |
BALANCE OF CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
126 |
BALANCE OF CASH AND CASH EQUIVALENTS AT END OF PERIOD |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
127 |
SUPPLEMENTARY INFORMATION ON INTEREST RECEIVED IN CASH |
Concept (Monetary) |
For Period |
Debit |
rdhl:SupplementalInformationInterestReceivedInCash |
128 |
10101 - Disclosure - GENERAL |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureGeneral |
129 |
Implied Table |
Table |
* |
* |
implied:Table |
130 |
GENERAL |
Abstract |
|
|
rdhl:GeneralInformationAbstract |
131 |
GENERAL |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DisclosureOfGeneralInformationAboutEntityTextBlock |
132 |
10201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSummaryOfSignificantAccountingPolicies |
133 |
Implied Table |
Table |
* |
* |
implied:Table |
134 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Abstract |
|
|
rdhl:IfrsAccountingPoliciesAbstract |
135 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory |
136 |
10301 - Disclosure - CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCriticalAccountingEstimatesAndJudgments |
137 |
Implied Table |
Table |
* |
* |
implied:Table |
138 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS |
Abstract |
|
|
rdhl:AccountingJudgmentsAndEstimatesAbstract |
139 |
CRITICAL ACCOUNTING ESTIMATES AND JUDGMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory |
140 |
10401 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagement |
141 |
Implied Table |
Table |
* |
* |
implied:Table |
142 |
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
143 |
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DisclosureOfFinancialInstrumentsAndFinancialRiskManagementTextBlock |
144 |
10501 - Disclosure - CASH, CASH EQUIVALENTS AND BANK DEPOSITS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCashCashEquivalentsAndBankDeposits |
145 |
Implied Table |
Table |
* |
* |
implied:Table |
146 |
CASH, CASH EQUIVALENTS AND BANK DEPOSITS |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
147 |
CASH, CASH EQUIVALENTS AND BANK DEPOSITS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory |
148 |
10601 - Disclosure - FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialAssetsAtFairValueThroughProfitOrLoss |
149 |
Implied Table |
Table |
* |
* |
implied:Table |
150 |
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS. |
Abstract |
|
|
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLossAbstract |
151 |
FINANCIAL ASSETS AT FAIR VALUE THROUGH PROFIT OR LOSS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinancialInstrumentsAtFairValueThroughProfitOrLossExplanatory |
152 |
10701 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosurePrepaidExpensesAndOtherReceivables |
153 |
Implied Table |
Table |
* |
* |
implied:Table |
154 |
PREPAID EXPENSES AND OTHER RECEIVABLES |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
155 |
PREPAID EXPENSES AND OTHER RECEIVABLES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory |
156 |
10801 - Disclosure - INVENTORY |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureInventory |
157 |
Implied Table |
Table |
* |
* |
implied:Table |
158 |
INVENTORY |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
159 |
INVENTORY |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInventoriesExplanatory |
160 |
10901 - Disclosure - FIXED ASSETS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFixedAssets |
161 |
Implied Table |
Table |
* |
* |
implied:Table |
162 |
FIXED ASSETS |
Abstract |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract |
163 |
FIXED ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory |
164 |
11001 - Disclosure - INTANGIBLE ASSETS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIntangibleAssets |
165 |
Implied Table |
Table |
* |
* |
implied:Table |
166 |
INTANGIBLE ASSETS |
Abstract |
|
|
ifrs-full:DisclosureOfIntangibleAssetsAbstract |
167 |
INTANGIBLE ASSETS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsExplanatory |
168 |
11101 - Disclosure - LIABILITY FOR EMPLOYEE RIGHTS UPON RETIREMENT |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLiabilityForEmployeeRightsUponRetirement |
169 |
Implied Table |
Table |
* |
* |
implied:Table |
170 |
LIABILITY FOR EMPLOYEE RIGHTS UPON RETIREMENT |
Abstract |
|
|
rdhl:DisclosureOfEmployeeBenefitsAbstract |
171 |
LIABILITY FOR EMPLOYEE RIGHTS UPON RETIREMENT |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEmployeeBenefitsExplanatory |
172 |
11201 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilities |
173 |
Implied Table |
Table |
* |
* |
implied:Table |
174 |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
Abstract |
|
|
ifrs-full:MiscellaneousCurrentLiabilitiesAbstract |
175 |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfAccruedExpensesAndOtherLiabilitiesExplanatory |
176 |
11301 - Disclosure - COMMITMENTS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCommitments |
177 |
Implied Table |
Table |
* |
* |
implied:Table |
178 |
COMMITMENTS |
Abstract |
|
|
rdhl:CommitmentsDisclosureAbstract |
179 |
COMMITMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfCommitmentsExplanatory |
180 |
11401 - Disclosure - INCOME TAX |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIncomeTax |
181 |
Implied Table |
Table |
* |
* |
implied:Table |
182 |
INCOME TAX |
Abstract |
|
|
ifrs-full:MajorComponentsOfTaxExpenseIncomeAbstract |
183 |
INCOME TAX |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIncomeTaxExplanatory |
184 |
11501 - Disclosure - EQUITY |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureEquity |
185 |
Implied Table |
Table |
* |
* |
implied:Table |
186 |
EQUITY |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
187 |
EQUITY |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory |
188 |
11601 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureDerivativeFinancialInstruments |
189 |
Implied Table |
Table |
* |
* |
implied:Table |
190 |
DERIVATIVE FINANCIAL INSTRUMENTS |
Abstract |
|
|
ifrs-full:DisclosureOfHedgeAccountingAbstract |
191 |
DERIVATIVE FINANCIAL INSTRUMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory |
192 |
11701 - Disclosure - SHARE-BASED PAYMENTS |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPayments |
193 |
Implied Table |
Table |
* |
* |
implied:Table |
194 |
SHARE-BASED PAYMENTS |
Abstract |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract |
195 |
SHARE-BASED PAYMENTS |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSharebasedPaymentArrangementsExplanatory |
196 |
11801 - Disclosure - NET REVENUES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureNetRevenues |
197 |
Implied Table |
Table |
* |
* |
implied:Table |
198 |
NET REVENUES |
Abstract |
|
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract |
199 |
NET REVENUES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory |
200 |
11901 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, net |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureResearchAndDevelopmentExpensesNet |
201 |
Implied Table |
Table |
* |
* |
implied:Table |
202 |
RESEARCH AND DEVELOPMENT EXPENSES, net. |
Abstract |
|
|
rdhl:IfrsResearchAndDevelopmentAbstract |
203 |
RESEARCH AND DEVELOPMENT EXPENSES, net |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DisclosureOfResearchAndDevelopmentExpenseTextBlock |
204 |
12001 - Disclosure - SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSellingMarketingAndBusinessDevelopmentExpenses |
205 |
Implied Table |
Table |
* |
* |
implied:Table |
206 |
SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES |
Abstract |
|
|
rdhl:SellingMarketingAndBusinessDevelopmentExpensesAbstract |
207 |
SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:SellingMarketingAndBusinessDevelopmentExpensesTextBlock |
208 |
12101 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureGeneralAndAdministrativeExpenses |
209 |
Implied Table |
Table |
* |
* |
implied:Table |
210 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Abstract |
|
|
ifrs-full:SellingGeneralAndAdministrativeExpenseAbstract |
211 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfGeneralAndAdministrativeExpenseExplanatory |
212 |
12201 - Disclosure - FINANCIAL INCOME, net |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialIncomeNet |
213 |
Implied Table |
Table |
* |
* |
implied:Table |
214 |
FINANCIAL INCOME, net |
Abstract |
|
|
rdhl:FinanceExpensesIncomeNetAbstract |
215 |
FINANCIAL INCOME, net |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:FinanceExpensesIncomeNetTextBlock |
216 |
12301 - Disclosure - SEGMENT INFORMATION |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSegmentInformation |
217 |
Implied Table |
Table |
* |
* |
implied:Table |
218 |
SEGMENT INFORMATION |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
219 |
SEGMENT INFORMATION |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory |
220 |
12401 - Disclosure - LOSS PER ORDINARY SHARE |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLossPerOrdinaryShare |
221 |
Implied Table |
Table |
* |
* |
implied:Table |
222 |
LOSS PER ORDINARY SHARE |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
223 |
LOSS PER ORDINARY SHARE |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEarningsPerShareExplanatory |
224 |
12501 - Disclosure - RELATED PARTIES |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureRelatedParties |
225 |
Implied Table |
Table |
* |
* |
implied:Table |
226 |
RELATED PARTIES |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
227 |
RELATED PARTIES |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfRelatedPartyExplanatory |
228 |
12601 - Disclosure - EVENTS SUBSEQUENT TO DECEMBER 31, 2018 |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureEventsSubsequentToDecember312018 |
229 |
Implied Table |
Table |
* |
* |
implied:Table |
230 |
EVENTS SUBSEQUENT TO DECEMBER 31, 2018 |
Abstract |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract |
231 |
EVENTS SUBSEQUENT TO DECEMBER 31, 2018 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory |
232 |
20202 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies |
233 |
Implied Table |
Table |
* |
* |
implied:Table |
234 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Abstract |
|
|
rdhl:IfrsAccountingPoliciesAbstract |
235 |
Basis for presentation of the financial statements |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory |
236 |
Translation of foreign currency balances and transactions |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForForeignCurrencyTranslationExplanatory |
237 |
Principles of consolidation |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfBasisOfConsolidationExplanatory |
238 |
Cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents |
239 |
Trade receivables |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForTradeAndOtherReceivablesExplanatory |
240 |
Inventory |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories |
241 |
Fixed assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory |
242 |
Research and development |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForResearchAndDevelopmentExpenseExplanatory |
243 |
Impairment of non-financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForImpairmentOfNonfinancialAssetsExplanatory |
244 |
Financial assets |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialAssetsExplanatory |
245 |
Financial liabilities |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForFinancialLiabilitiesExplanatory |
246 |
Share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForIssuedCapitalExplanatory |
247 |
Employee benefits |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEmployeeBenefitsExplanatory |
248 |
Share-based payments |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForSharebasedPaymentTransactionsExplanatory |
249 |
Revenue from contracts with customers |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForRecognitionOfRevenue |
250 |
Advertising and promotional expenses |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:AdvertisingAndPromotionalExpensesPolicyTextBlock |
251 |
Leases |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory |
252 |
Loss per ordinary share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForEarningsPerShareExplanatory |
253 |
Deferred taxes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfAccountingPolicyForDeferredIncomeTaxExplanatory |
254 |
Standards and interpretations to existing standards that are not yet in effect and have not been early adopted by the Company |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations |
255 |
30203 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables |
256 |
Implied Table |
Table |
* |
* |
implied:Table |
257 |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES |
Abstract |
|
|
rdhl:IfrsAccountingPoliciesAbstract |
258 |
Schedule of estimated useful lives of fixed assets |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DepreciationRatePropertyPlantAndEquipmentTableTextBlock |
259 |
30503 - Disclosure - CASH, CASH EQUIVALENTS AND BANK DEPOSITS (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCashCashEquivalentsAndBankDepositsTables |
260 |
Implied Table |
Table |
* |
* |
implied:Table |
261 |
CASH, CASH EQUIVALENTS AND BANK DEPOSITS |
Abstract |
|
|
ifrs-full:CashAndCashEquivalentsAbstract |
262 |
Schedule of cash and cash equivalents |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DisclosureOfCashAndCashEquivalentsTableTextBlock |
263 |
30603 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementTables |
264 |
Implied Table |
Table |
* |
* |
implied:Table |
265 |
FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT |
Abstract |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsAbstract |
266 |
Schedule of assets and liabilities measured at fair value |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFairValueOfFinancialInstrumentsExplanatory |
267 |
Schedule of change in derivative liabilities measured at Level 3 |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfSignificantUnobservableInputsUsedInFairValueMeasurementOfLiabilitiesExplanatory |
268 |
30703 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosurePrepaidExpensesAndOtherReceivablesTables |
269 |
Implied Table |
Table |
* |
* |
implied:Table |
270 |
PREPAID EXPENSES AND OTHER RECEIVABLES |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
271 |
Schedule of prepaid expenses and other receivables |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:DisclosureOfDetailedInformationAboutPrepaidExpensesAndReceivablesTableTextBlock |
272 |
30803 - Disclosure - INVENTORY (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureInventoryTables |
273 |
Implied Table |
Table |
* |
* |
implied:Table |
274 |
INVENTORY |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
275 |
Schedule of Inventory |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:ScheduleOfInventoryTableTextBlock |
276 |
30903 - Disclosure - FIXED ASSETS (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFixedAssetsTables |
277 |
Implied Table |
Table |
* |
* |
implied:Table |
278 |
FIXED ASSETS |
Abstract |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentAbstract |
279 |
Schedule of composition of assets and accumulated depreciation, grouped by major classifications |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory |
280 |
31003 - Disclosure - INTANGIBLE ASSETS (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIntangibleAssetsTables |
281 |
Implied Table |
Table |
* |
* |
implied:Table |
282 |
INTANGIBLE ASSETS |
Abstract |
|
|
ifrs-full:DisclosureOfIntangibleAssetsAbstract |
283 |
Schedule of intangible assets changes |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfIntangibleAssetsWithIndefiniteUsefulLifeExplanatory |
284 |
31201 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables |
285 |
Implied Table |
Table |
* |
* |
implied:Table |
286 |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
Abstract |
|
|
ifrs-full:MiscellaneousCurrentLiabilitiesAbstract |
287 |
Schedule of accrued expenses and other current liabilities |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock |
288 |
31303 - Disclosure - COMMITMENTS (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCommitmentsTables |
289 |
Implied Table |
Table |
* |
* |
implied:Table |
290 |
COMMITMENTS |
Abstract |
|
|
rdhl:CommitmentsDisclosureAbstract |
291 |
Schedule of operating lease agreements |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLessorExplanatory |
292 |
31503 - Disclosure - EQUITY (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureEquityTables |
293 |
Implied Table |
Table |
* |
* |
implied:Table |
294 |
EQUITY |
Abstract |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalAbstract |
295 |
Schedule of composition of share capital |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory |
296 |
31703 - Disclosure - SHARE-BASED PAYMENTS (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPaymentsTables |
297 |
Implied Table |
Table |
* |
* |
implied:Table |
298 |
SHARE-BASED PAYMENTS |
Abstract |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract |
299 |
Schedule of information on options granted |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementExplanatory |
300 |
Schedule of number of shares and weighted averages of exercise prices |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory |
301 |
Schedule of information about exercise price and remaining useful life of outstanding options |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsExplanatory |
302 |
Schedule of expenses recognized in profit or loss |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:ExplanationOfEffectOfSharebasedPaymentsOnProfitOrLoss |
303 |
31803 - Disclosure - NET REVENUES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureNetRevenuesTables |
304 |
Implied Table |
Table |
* |
* |
implied:Table |
305 |
NET REVENUES |
Abstract |
|
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract |
306 |
Schedule of net revenues |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory |
307 |
31903 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, net (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureResearchAndDevelopmentExpensesNetTables |
308 |
Implied Table |
Table |
* |
* |
implied:Table |
309 |
RESEARCH AND DEVELOPMENT EXPENSES, net. |
Abstract |
|
|
rdhl:IfrsResearchAndDevelopmentAbstract |
310 |
Schedule of research and development expenses, net |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfResearchAndDevelopmentExpenseExplanatory |
311 |
32003 - Disclosure - SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSellingMarketingAndBusinessDevelopmentExpensesTables |
312 |
Implied Table |
Table |
* |
* |
implied:Table |
313 |
SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES |
Abstract |
|
|
rdhl:SellingMarketingAndBusinessDevelopmentExpensesAbstract |
314 |
Schedule of selling, marketing and business development expenses |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:SellingMarketingAndBusinessDevelopmentExpensesTableTextBlock |
315 |
32103 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureGeneralAndAdministrativeExpensesTables |
316 |
Implied Table |
Table |
* |
* |
implied:Table |
317 |
GENERAL AND ADMINISTRATIVE EXPENSES |
Abstract |
|
|
ifrs-full:SellingGeneralAndAdministrativeExpenseAbstract |
318 |
Schedule of general and administrative expenses |
Concept (Text Block (HTML)) |
For Period |
|
rdhl:GeneralAndAdministrativeExpenseTableTextBlock |
319 |
32203 - Disclosure - FINANCIAL INCOME, net (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialIncomeNetTables |
320 |
Implied Table |
Table |
* |
* |
implied:Table |
321 |
FINANCIAL INCOME, net |
Abstract |
|
|
rdhl:FinanceExpensesIncomeNetAbstract |
322 |
Schedule of financial income, net |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory |
323 |
32303 - Disclosure - SEGMENT INFORMATION (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSegmentInformationTables |
324 |
Implied Table |
Table |
* |
* |
implied:Table |
325 |
SEGMENT INFORMATION |
Abstract |
|
|
ifrs-full:DisclosureOfOperatingSegmentsAbstract |
326 |
Schedule of segment information |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfOperatingSegmentsExplanatory |
327 |
32403 - Disclosure - LOSS PER ORDINARY SHARE (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLossPerOrdinaryShareTables |
328 |
Implied Table |
Table |
* |
* |
implied:Table |
329 |
LOSS PER ORDINARY SHARE |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
330 |
Schedule of loss per ordinary share |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:EarningsPerShareExplanatory |
331 |
32503 - Disclosure - RELATED PARTIES (Tables) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureRelatedPartiesTables |
332 |
Implied Table |
Table |
* |
* |
implied:Table |
333 |
RELATED PARTIES |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
334 |
Schedule of key management compensation: |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfInformationAboutKeyManagementPersonnelExplanatory |
335 |
Schedule of balances with related parties |
Concept (Text Block (HTML)) |
For Period |
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory |
336 |
40101 - Disclosure - GENERAL (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureGeneralDetails |
337 |
General [Table] |
Table |
* |
* |
rdhl:GeneralTable |
338 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
339 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
340 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
341 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
342 |
Products and services [axis] |
Axis |
|
|
ifrs-full:ProductsAndServicesAxis |
343 |
Products and services [member] |
Member |
|
|
ifrs-full:ProductsAndServicesMember |
344 |
EnteraGam [member] |
Member |
|
|
rdhl:EnteragamMember |
345 |
Donnatal and Mytesi [member] |
Member |
|
|
rdhl:DonnatalAndMytesiMember |
346 |
General [Line Items] |
LineItems |
|
|
rdhl:GeneralLineItems |
347 |
Agreement Term |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:AgreementTerm |
348 |
40201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails |
349 |
Accounting Policies [Table] |
Table |
* |
* |
rdhl:AccountingPoliciesTable |
350 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
351 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
352 |
Computer equipment |
Member |
|
|
ifrs-full:ComputerEquipmentMember |
353 |
Office furniture and equipment |
Member |
|
|
ifrs-full:OfficeEquipmentMember |
354 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
355 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
356 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
357 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
358 |
Forecast |
Member |
|
|
rdhl:IfrsScenarioForecastMember |
359 |
Accounting Policies [Line Items] |
LineItems |
|
|
rdhl:AccountingPoliciesLineItems |
360 |
Depreciation rate (as a percent) |
Concept (Percent) |
For Period |
|
rdhl:DepreciationRatesPropertyPlantAndEquipment |
361 |
IFRS 16 |
Abstract |
|
|
ifrs-full:PresentationOfLeasesForLesseeAbstract |
362 |
Recognition of right-of-use assets and lease liabilities |
Concept (Monetary) |
For Period |
Debit |
rdhl:RecognitionOfRightOfUseAssetsAndLeaseLiabilities |
363 |
Decrease in cash flows from financing activities |
Concept (Monetary) |
For Period |
Debit |
rdhl:IncreaseDecreaseInCashFlowsFromUsedInFinancingActivities |
364 |
40401 - Disclosure - FINANCIAL INSTRUMENTS AND FINANCIAL RISK MANAGEMENT (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialInstrumentsAndFinancialRiskManagementDetails |
365 |
Disclosure of detailed information about financial instruments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinancialInstrumentsTable |
366 |
Levels of fair value hierarchy [axis] |
Axis |
|
|
ifrs-full:LevelsOfFairValueHierarchyAxis |
367 |
All levels of fair value hierarchy [member] |
Member |
|
|
ifrs-full:AllLevelsOfFairValueHierarchyMember |
368 |
Level 1 |
Member |
|
|
ifrs-full:Level1OfFairValueHierarchyMember |
369 |
Level 3 |
Member |
|
|
ifrs-full:Level3OfFairValueHierarchyMember |
370 |
Measurement [axis] |
Axis |
|
|
ifrs-full:MeasurementAxis |
371 |
Aggregated measurement [member] |
Member |
|
|
ifrs-full:AggregatedMeasurementMember |
372 |
At fair value |
Member |
|
|
ifrs-full:AtFairValueMember |
373 |
Classes of liabilities [axis] |
Axis |
|
|
ifrs-full:ClassesOfLiabilitiesAxis |
374 |
Liabilities [member] |
Member |
|
|
ifrs-full:LiabilitiesMember |
375 |
Derivative financial instruments. |
Member |
|
|
ifrs-full:DerivativesMember |
376 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
377 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
378 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
379 |
Financial instruments |
LineItems |
|
|
ifrs-full:DisclosureOfFinancialInstrumentsLineItems |
380 |
Maturity periods for cash balances in highly-rated bank deposits |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:MaturityPeriodsForCashBalancesInHighlyRatedBankDeposits |
381 |
Portfolio invested in a single bond issuer (as a percent) |
Concept (Percent) |
For Period |
|
rdhl:PortfolioConcentrationRiskPercentage |
382 |
Percentage of currency stronger against the NIS |
Concept (Percent) |
As Of |
|
rdhl:PercentageOfReasonablyPossibleIncreaseInRiskAssumption |
383 |
Additional expense that would have been recognized |
Concept (Monetary) |
As Of |
Debit |
rdhl:IncreaseDecreaseInFinancialInstrumentDueToReasonablyPossibleIncreaseInDesignatedRiskComponent |
384 |
Period for non-derivative financial liabilities |
Concept (Integer) |
As Of |
|
rdhl:PeriodForNonDerivativeFinancialLiabilities |
385 |
Financial assets at fair value through profit or loss |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinancialAssetsAtFairValueThroughProfitOrLoss |
386 |
Derivative liabilities- balance at beginning of the period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilities |
387 |
Exercise of derivative into shares |
Concept (Monetary) |
For Period |
Debit |
rdhl:AmountsClassifiedToEquityOfFairvalueMeasurementLiabilities |
388 |
Fair value adjustments recognized in profit or loss |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities |
389 |
Derivative liabilities- balance at end of the period |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:DerivativeFinancialLiabilities |
390 |
40501 - Disclosure - CASH, CASH EQUIVALENTS AND BANK DEPOSITS (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCashCashEquivalentsAndBankDepositsDetails |
391 |
Schedule of Cash and Cash Equivalents [Table] |
Table |
* |
* |
us-gaap:ScheduleOfCashAndCashEquivalentsTable |
392 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
393 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
394 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
395 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
396 |
Cash and Cash Equivalents [Line Items] |
LineItems |
|
|
us-gaap:CashAndCashEquivalentsLineItems |
397 |
Cash in bank |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Cash |
398 |
Short-term bank deposits |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents |
399 |
Cash and cash equivalents |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CashAndCashEquivalents |
400 |
Bank deposits, term |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:BankDepositsTerm |
401 |
Bank deposits, annual interest rate |
Concept (Percent) |
For Period |
|
rdhl:BankDepositsAnnualInterestRates |
402 |
40701 - Disclosure - PREPAID EXPENSES AND OTHER RECEIVABLES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosurePrepaidExpensesAndOtherReceivablesDetails |
403 |
Implied Table |
Table |
* |
* |
implied:Table |
404 |
PREPAID EXPENSES AND OTHER RECEIVABLES |
Abstract |
|
|
ifrs-full:TradeAndOtherReceivablesAbstract |
405 |
Advances to suppliers |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentAdvancesToSuppliers |
406 |
Discount from service provider |
Concept (Monetary) |
As Of |
Debit |
rdhl:DiscountFromServiceProvider |
407 |
Prepaid expenses |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:CurrentPrepaidExpenses |
408 |
Government institutions |
Concept (Monetary) |
As Of |
Debit |
rdhl:CurrentReceivablesFromGovernmentInstitutions |
409 |
Total prepaid expenses and other receivables |
Concept (Monetary) |
As Of |
Debit |
rdhl:CurrentPrepaidExpensesAndReceivables |
410 |
40801 - Disclosure - INVENTORY (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureInventoryDetails |
411 |
Implied Table |
Table |
* |
* |
implied:Table |
412 |
INVENTORY |
Abstract |
|
|
ifrs-full:ClassesOfInventoriesAbstract |
413 |
Raw materials |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:RawMaterials |
414 |
Finished goods |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:FinishedGoods |
415 |
Total current inventories |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:Inventories |
416 |
Inventories recognized as part of cost of revenues |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:InventoriesAtFairValueLessCostsToSell |
417 |
40901 - Disclosure - FIXED ASSETS (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFixedAssetsDetails |
418 |
Disclosure of detailed information about property, plant and equipment [table] |
Table |
* |
* |
ifrs-full:DisclosureOfPropertyPlantAndEquipmentTable |
419 |
Classes of property, plant and equipment [axis] |
Axis |
|
|
ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis |
420 |
Property, plant and equipment [member] |
Member |
|
|
ifrs-full:PropertyPlantAndEquipmentMember |
421 |
Office furniture and equipment (including computers) |
Member |
|
|
rdhl:OfficeFurnitureAndEquipmentAndComputersMember |
422 |
Leasehold improvements |
Member |
|
|
ifrs-full:LeaseholdImprovementsMember |
423 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
424 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
425 |
Cost |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
426 |
Accumulated depreciation |
Member |
|
|
ifrs-full:AccumulatedDepreciationAndAmortisationMember |
427 |
Fixed assets |
LineItems |
|
|
ifrs-full:DisclosureOfPropertyPlantAndEquipmentLineItems |
428 |
Fixed assets |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:PropertyPlantAndEquipment |
429 |
41001 - Disclosure - INTANGIBLE ASSETS - Changes in Assets (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIntangibleAssetsChangesInAssetsDetails |
430 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
431 |
Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis] |
Axis |
|
|
ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis |
432 |
Carrying amount [member] |
Member |
|
|
ifrs-full:CarryingAmountMember |
433 |
Cost |
Member |
|
|
ifrs-full:GrossCarryingAmountMember |
434 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
435 |
Reconciliation of changes in intangible assets |
Abstract |
|
|
ifrs-full:ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract |
436 |
Balance at beginning of year |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
437 |
Additions during the year |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill |
438 |
Deductions during the year |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill |
439 |
Write-off charge |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill |
440 |
Balance at end of year |
Concept (Monetary) |
As Of |
Debit |
ifrs-full:IntangibleAssetsOtherThanGoodwill |
441 |
41002 - Disclosure - INTANGIBLE ASSETS - Narrative (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIntangibleAssetsNarrativeDetails |
442 |
Disclosure of detailed information about intangible assets [table] |
Table |
* |
* |
ifrs-full:DisclosureOfIntangibleAssetsTable |
443 |
Classes of intangible assets other than goodwill [axis] |
Axis |
|
|
ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis |
444 |
Intangible assets other than goodwill [member] |
Member |
|
|
ifrs-full:IntangibleAssetsOtherThanGoodwillMember |
445 |
Drug candidate, congestive heart failure |
Member |
|
|
rdhl:DrugCandidateCongestiveHeartFailureMember |
446 |
Therapeutic candidate, acute migraine |
Member |
|
|
rdhl:TherapeuticCandidateAcuteMigraineMember |
447 |
Therapeutic candidate, pancreatic cancer |
Member |
|
|
rdhl:TherapeuticCandidatePancreaticCancerMember |
448 |
Disclosure of detailed information about intangible assets [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfIntangibleAssetsLineItems |
449 |
Reconciliation of changes in intangible assets |
Abstract |
|
|
ifrs-full:ReconciliationOfChangesInIntangibleAssetsOtherThanGoodwillAbstract |
450 |
Recognized loss |
Concept (Monetary) |
For Period |
|
ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill |
451 |
41101 - Disclosure - LIABILITY FOR EMPLOYEE RIGHTS UPON RETIREMENT (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLiabilityForEmployeeRightsUponRetirementDetails |
452 |
Implied Table |
Table |
* |
* |
implied:Table |
453 |
LIABILITY FOR EMPLOYEE RIGHTS UPON RETIREMENT |
Abstract |
|
|
rdhl:DisclosureOfEmployeeBenefitsAbstract |
454 |
Defined contribution plans expense |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:PostemploymentBenefitExpenseDefinedContributionPlans |
455 |
41201 - Disclosure - ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureAccruedExpensesAndOtherCurrentLiabilitiesDetails |
456 |
Implied Table |
Table |
* |
* |
implied:Table |
457 |
ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES |
Abstract |
|
|
ifrs-full:MiscellaneousCurrentLiabilitiesAbstract |
458 |
Accrued expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AccrualsClassifiedAsCurrent |
459 |
Employees and related liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:ShorttermEmployeeBenefitsAccruals |
460 |
Government Institutions |
Concept (Monetary) |
As Of |
Credit |
rdhl:GovernmentInstitutionsPayablesAndAccruedExpenses |
461 |
Accrued expenses and other current liabilities |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:CurrentAccruedExpensesAndOtherCurrentLiabilities |
462 |
41301 - Disclosure - COMMITMENTS - Agreements to Purchase IP (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCommitmentsAgreementsToPurchaseIpDetails |
463 |
Schedule of Collaborative Arrangements Transactions [Table] |
Table |
* |
* |
rdhl:ScheduleOfCollaborativeArrangementsTransactionsTable |
464 |
Type of Arrangement Transactions [Axis] |
Axis |
|
|
rdhl:TypeOfArrangementTransactionsAxis |
465 |
Arrangements Transactions [Member] |
Member |
|
|
rdhl:ArrangementsTransactionsMember |
466 |
Australian Asset Purchase Agreement |
Member |
|
|
rdhl:AustralianAssetPurchaseAgreementMember |
467 |
Salix Pharmaceuticals, Ltd. Agreement [Member] |
Member |
|
|
rdhl:SalixPharmaceuticalsLtd.AgreementMember |
468 |
German Publicly Traded Company Arrangement |
Member |
|
|
rdhl:GermanPubliclyTradedCompanyArrangementMember |
469 |
U.S. Private Company Arrangement |
Member |
|
|
rdhl:U.s.PrivateCompanyArrangementMember |
470 |
Milestone [Axis] |
Axis |
|
|
rdhl:MilestoneAxis |
471 |
Milestone [Domain] |
Member |
|
|
rdhl:MilestoneDomain |
472 |
Revenue Milestone |
Member |
|
|
rdhl:RevenueMilestoneMember |
473 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
474 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
475 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
476 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
477 |
Commitments |
LineItems |
|
|
rdhl:CollaborativeArrangementsTransactionsLineItems |
478 |
Number of therapeutic candidates |
Concept (Integer) |
For Period |
|
rdhl:NumberOfTherapeuticCandidates |
479 |
Upfront initial payment per agreement |
Concept (Monetary) |
For Period |
Credit |
rdhl:UpfrontInitialPaymentPerAgreement |
480 |
Percentage of revenues to be paid in the future |
Concept (Percent) |
For Period |
|
rdhl:PercentageRevenuesExpectedToBePaid |
481 |
Milestones to be paid |
Concept (Monetary) |
As Of |
Credit |
rdhl:MilestonesToBePaid |
482 |
Aggregate payments made |
Concept (Monetary) |
As Of |
Credit |
rdhl:AggregatePaymentsAsOfReportingPeriod |
483 |
Royalties percentage |
Concept (Percent) |
For Period |
|
rdhl:RoyaltiesPercentage |
484 |
41302 - Disclosure - COMMITMENTS - Operating Lease Agreements (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureCommitmentsOperatingLeaseAgreementsDetails |
485 |
Disclosure of finance lease and operating lease by lessee [table] |
Table |
* |
* |
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeTable |
486 |
Maturity [axis] |
Axis |
|
|
ifrs-full:MaturityAxis |
487 |
Aggregated time bands [member] |
Member |
|
|
ifrs-full:AggregatedTimeBandsMember |
488 |
Less than 1 year |
Member |
|
|
ifrs-full:NotLaterThanOneYearMember |
489 |
2-5 years |
Member |
|
|
ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember |
490 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
491 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
492 |
Israel |
Member |
|
|
country:IL |
493 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
494 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
495 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
496 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
497 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
498 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
499 |
Amendment to lease agreement [member] |
Member |
|
|
rdhl:AmendmentToLeaseAgreementMember |
500 |
Disclosure of finance lease and operating lease by lessee [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeLineItems |
501 |
Operating lease |
Abstract |
|
|
ifrs-full:DisclosureOfFinanceLeaseAndOperatingLeaseByLesseeAbstract |
502 |
Operating lease, term |
Concept (xbrli:durationItemType) |
As Of |
|
us-gaap:LesseeOperatingLeaseTermOfContract |
503 |
Obligations under non-cancellable operating lease |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:MinimumLeasePaymentsPayableUnderNoncancellableOperatingLease |
504 |
Amount deposited with bank to secure lease obligation |
Concept (Monetary) |
As Of |
Credit |
rdhl:AmountToSecureLeaseObligation |
505 |
41401 - Disclosure - INCOME TAX (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureIncomeTaxDetails |
506 |
Income Tax [Table] |
Table |
* |
* |
rdhl:IncomeTaxTable |
507 |
IFRS Statement Scenario [Axis] |
Axis |
|
|
rdhl:IfrsStatementScenarioAxis |
508 |
IFRS Scenario Unspecified [Domain] |
Member |
|
|
rdhl:IfrsScenarioUnspecifiedDomain |
509 |
Forecast |
Member |
|
|
rdhl:IfrsScenarioForecastMember |
510 |
Geographical areas [axis] |
Axis |
|
|
ifrs-full:GeographicalAreasAxis |
511 |
Geographical areas [member] |
Member |
|
|
ifrs-full:GeographicalAreasMember |
512 |
Israel |
Member |
|
|
country:IL |
513 |
U.S. |
Member |
|
|
country:US |
514 |
Temporary difference, unused tax losses and unused tax credits [axis] |
Axis |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis |
515 |
Temporary difference, unused tax losses and unused tax credits [member] |
Member |
|
|
ifrs-full:TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsMember |
516 |
Net operating losses |
Member |
|
|
ifrs-full:UnusedTaxLossesMember |
517 |
Net operating losses expiring in 2037 [Member] |
Member |
|
|
rdhl:UnusedTaxLossesExpiry1Member |
518 |
Net operating losses with no expiriation [Member] |
Member |
|
|
rdhl:UnusedTaxLossesNoExpiryMember |
519 |
Income Tax [Line Items] |
LineItems |
|
|
rdhl:IncomeTaxLineItems |
520 |
Corporate tax rate |
Concept (Percent) |
For Period |
|
ifrs-full:ApplicableTaxRate |
521 |
Net operating losses |
Concept (Monetary) |
As Of |
|
ifrs-full:UnusedTaxLossesForWhichNoDeferredTaxAssetRecognised |
522 |
Deductible temporary differences |
Concept (Monetary) |
As Of |
|
ifrs-full:DeductibleTemporaryDifferencesForWhichNoDeferredTaxAssetIsRecognised |
523 |
41501 - Disclosure - EQUITY (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureEquityDetails |
524 |
Disclosure of classes of share capital [table] |
Table |
* |
* |
ifrs-full:DisclosureOfClassesOfShareCapitalTable |
525 |
Components of equity [axis] |
Axis |
|
|
ifrs-full:ComponentsOfEquityAxis |
526 |
Equity [member] |
Member |
|
|
ifrs-full:EquityMember |
527 |
Ordinary shares and warrants |
Member |
|
|
rdhl:IssuedCapitalAndWarrantsMember |
528 |
Ordinary shares |
Member |
|
|
ifrs-full:IssuedCapitalMember |
529 |
Warrants |
Member |
|
|
rdhl:WarrantsMember |
530 |
Classes of ordinary shares [axis] |
Axis |
|
|
ifrs-full:ClassesOfOrdinarySharesAxis |
531 |
Ordinary shares [member] |
Member |
|
|
ifrs-full:OrdinarySharesMember |
532 |
American Depository Shares |
Member |
|
|
rdhl:AmericanDepositorySharesMember |
533 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
534 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
535 |
Stock Options |
Member |
|
|
rdhl:IfrsEmployeeStockOptionMember |
536 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
537 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
538 |
Underwriters |
Member |
|
|
rdhl:UnderwritersMember |
539 |
Disclosure of classes of share capital [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfClassesOfShareCapitalLineItems |
540 |
Par value per share |
Concept (Share) |
As Of |
|
ifrs-full:ParValuePerShare |
541 |
Authorized |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesAuthorised |
542 |
Issued and paid |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssuedAndFullyPaid |
543 |
American depository share equivalent |
Concept (Shares) |
As Of |
|
rdhl:AmericanDepositoryShareEquivalent |
544 |
Market price per American Depository share |
Concept (Share) |
As Of |
|
rdhl:MarketPricePerAmericanDepositoryShare |
545 |
Market price per ordinary share |
Concept (Share) |
As Of |
|
rdhl:MarketPricePerOrdinaryShare |
546 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
547 |
Warrants issued |
Concept (Shares) |
For Period |
|
rdhl:WarrantsNumberIssued |
548 |
Proceeds from exercise of options |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromExerciseOfOptions |
549 |
Proceeds from issuance of shares, gross |
Concept (Monetary) |
For Period |
Debit |
rdhl:ProceedsFromIssuingSharesGross |
550 |
Share issue related costs |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ShareIssueRelatedCost |
551 |
Proceeds from issuance of shares |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ProceedsFromIssuingShares |
552 |
Procceds from issuance of ordinary shares and warrants |
Concept (Monetary) |
For Period |
Debit |
rdhl:ProceedsFromIssueOfOrdinarySharesAndWarrantsGross |
553 |
41601 - Disclosure - DERIVATIVE FINANCIAL INSTRUMENTS (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureDerivativeFinancialInstrumentsDetails |
554 |
Disclosure of detailed information about hedges [table] |
Table |
* |
* |
ifrs-full:DisclosureOfHedgeAccountingTable |
555 |
Hedged items [axis] |
Axis |
|
|
ifrs-full:HedgedItemsAxis |
556 |
Hedged items [member] |
Member |
|
|
ifrs-full:HedgedItemsMember |
557 |
Warrants issued in 2014 |
Member |
|
|
rdhl:WarrantsIssuedInTwoThousandFourteenMember |
558 |
Warrants issued in 2016 |
Member |
|
|
rdhl:WarrantsIssuedInTwoThousandSixteenMember |
559 |
Disclosure of detailed information about hedges [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfHedgeAccountingLineItems |
560 |
Number of shares issued |
Concept (Shares) |
As Of |
|
ifrs-full:NumberOfSharesIssued |
561 |
Proceeds from warrant exercises |
Concept (Monetary) |
For Period |
Debit |
rdhl:IfrsProceedsFromWarrantExercises |
562 |
Number of warrants expired |
Concept (Shares) |
For Period |
|
rdhl:NumberOfWarrantsExpired |
563 |
Warrants exercisable into number of ADSs |
Concept (Shares) |
As Of |
|
rdhl:IfrsClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights |
564 |
Derivative term |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:IfrsDerivativeTermOfContract |
565 |
Risk-free interest rate |
Concept (Percent) |
For Period |
|
rdhl:IfrsFairValueAssumptionsRiskFreeInterestRate |
566 |
Average standard deviation |
Concept (Percent) |
For Period |
|
rdhl:FairValueAssumptionsAverageStandardDeviation |
567 |
Warrants exercise price |
Concept (Share) |
As Of |
|
rdhl:IfrsClassOfWarrantOrRightExercisePriceOfWarrantsOrRights |
568 |
41701 - Disclosure - SHARE-BASED PAYMENTS (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPaymentsDetails |
569 |
Disclosure of terms and conditions of share-based payment arrangement [table] |
Table |
* |
* |
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable |
570 |
Categories of related parties [axis] |
Axis |
|
|
ifrs-full:CategoriesOfRelatedPartiesAxis |
571 |
Entity's total for related parties [member] |
Member |
|
|
ifrs-full:EntitysTotalForRelatedPartiesMember |
572 |
Other than directors |
Member |
|
|
rdhl:OtherThanDirectorsMember |
573 |
To directors |
Member |
|
|
ifrs-full:KeyManagementPersonnelOfEntityOrParentMember |
574 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
575 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
576 |
Stock Options |
Member |
|
|
rdhl:IfrsEmployeeStockOptionMember |
577 |
Award Date [Axis] |
Axis |
|
|
us-gaap:AwardDateAxis |
578 |
Award Date [Domain] |
Member |
|
|
us-gaap:AwardDateDomain |
579 |
2018 |
Member |
|
|
rdhl:YearOfGrantTwoThousandEighteenMember |
580 |
January 2018 |
Member |
|
|
rdhl:DateOfGrantJanuaryTwoThousandEighteenMember |
581 |
March 2018 |
Member |
|
|
rdhl:DateOfGrantMarchTwoThousandEighteenMember |
582 |
May 2018 |
Member |
|
|
rdhl:DateOfGrantMayTwoThousandEighteenMember |
583 |
August 2018 |
Member |
|
|
rdhl:DateOfGrantAugustTwoThousandEighteenMember |
584 |
November 2018 |
Member |
|
|
rdhl:DateOfGrantNovemberTwoThousandEighteenMember |
585 |
2017 |
Member |
|
|
rdhl:YearOfGrantTwoThousandSeventeenMember |
586 |
March 2017 |
Member |
|
|
rdhl:DateOfGrantMarchTwoThousandSeventeenMember |
587 |
May 2017, first tranche |
Member |
|
|
rdhl:DateOfGrantMayTwoThousandSeventeenTrancheOneMember |
588 |
May 2017, second tranche |
Member |
|
|
rdhl:DateOfGrantMayTwoThousandSeventeenTrancheTwoMember |
589 |
July 2017 |
Member |
|
|
rdhl:DateOfGrantJulyTwoThousandSeventeenMember |
590 |
Vesting [Axis] |
Axis |
|
|
us-gaap:VestingAxis |
591 |
Vesting [Domain] |
Member |
|
|
us-gaap:VestingDomain |
592 |
Vesting, services exceeding one year |
Member |
|
|
us-gaap:ShareBasedCompensationAwardTrancheOneMember |
593 |
Vesting, services not exceeding one year |
Member |
|
|
us-gaap:ShareBasedCompensationAwardTrancheTwoMember |
594 |
Vesting, one year following the date of grant (services not exceeding one year) |
Member |
|
|
us-gaap:ShareBasedCompensationAwardTrancheThreeMember |
595 |
Vesting, three years following one year after the date of grant (services not exceeding one year) |
Member |
|
|
rdhl:ShareBasedCompensationAwardTrancheFourMember |
596 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
597 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
598 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
599 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
600 |
IFRS Statement Scenario [Axis] |
Axis |
|
|
rdhl:IfrsStatementScenarioAxis |
601 |
IFRS Scenario Unspecified [Domain] |
Member |
|
|
rdhl:IfrsScenarioUnspecifiedDomain |
602 |
Extension of options originally scheduled to expire in February 2018 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInFebruaryTwoThousandEighteenMember |
603 |
Extension of options originally scheduled to expire in March 2018 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInMarchTwoThousandEighteenMember |
604 |
Extension of options originally scheduled to expire in May 2018 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInMayTwoThousandEighteenMember |
605 |
Extension of options originally scheduled to expire in August 2018 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInAugustTwoThousandEighteenMember |
606 |
Extension of options originally scheduled to expire in January 2019 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInJanuaryTwoThousandNineteenMember |
607 |
Extension of options originally scheduled to expire in February 2019 |
Member |
|
|
rdhl:OptionsOriginallyScheduledToExpireInFebruary2019Member |
608 |
Disclosure of terms and conditions of share-based payment arrangement [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems |
609 |
Shares approved for issuance |
Concept (Shares) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
610 |
Number of options granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
611 |
Exercise price for 1 ordinary share ($) |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
612 |
Fair value of options on date of grant in U.S. $ thousands |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |
613 |
Service period |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod |
614 |
Number of equal quarterly vesting installments |
Concept (Integer) |
For Period |
|
rdhl:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfEqualQuarterlyVestingInstallments |
615 |
Vesting period |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 |
616 |
Percentage of options vesting |
Concept (Percent) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsPercentage |
617 |
Option term |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:ContractualLifeOfShareBasedAwards |
618 |
Price of the Company’s ordinary share |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageSharePriceShareOptionsGranted |
619 |
Expected volatility |
Concept (Percent) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate |
620 |
Risk free interest rate |
Concept (Percent) |
For Period |
|
ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted |
621 |
Extension of the exercise period |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisePeriodExtension |
622 |
Number of fully-vested options |
Concept (Shares) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedNumberOfShares |
623 |
Exercise price increase (as a percent) |
Concept (Percent) |
For Period |
|
rdhl:WeightedAverageExercisePriceOfShareOptionsGrantedInShareBasedPaymentArrangementPercentageIncrease |
624 |
Number of shares that were granted an extension |
Concept (Shares) |
For Period |
|
rdhl:IfrsShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesWithExtendedExercisePeriod |
625 |
Incremental fair value |
Concept (Monetary) |
For Period |
|
ifrs-full:IncrementalFairValueGrantedModifiedSharebasedPaymentArrangements |
626 |
Each option exercisable into number of ordinary shares, ratio |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
627 |
41702 - Disclosure - SHARE-BASED PAYMENTS - Number of Shares and Weighted Averages of Exercise Prices (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPaymentsNumberOfSharesAndWeightedAveragesOfExercisePricesDetails |
628 |
Implied Table |
Table |
* |
* |
implied:Table |
629 |
SHARE-BASED PAYMENTS |
Abstract |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract |
630 |
Number of options, outstanding at beginning of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
631 |
Number of options, exercised |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement |
632 |
Number of options, expired and forfeited |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement |
633 |
Number of options, granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
634 |
Number of options, outstanding at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
635 |
Number of options, exercisable at end of year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement |
636 |
Weighted average of exercise price, outstanding at beginning of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
637 |
Weighted average of exercise price, exercised |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement |
638 |
Weighted average of exercise price, expired and forfeited |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement |
639 |
Weighted average of exercise price, granted |
Concept (Monetary) |
For Period |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement |
640 |
Weighted average of exercise price, outstanding at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement |
641 |
Weighted average of exercise price, exercisable at end of year |
Concept (Monetary) |
As Of |
|
ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement |
642 |
41703 - Disclosure - SHARE-BASED PAYMENTS - Information About Exercise Price and Remaining Useful Life of Outstanding Options (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPaymentsInformationAboutExercisePriceAndRemainingUsefulLifeOfOutstandingOptionsDetails |
643 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsTable |
644 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
645 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
646 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
647 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
648 |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems |
649 |
Number of options outstanding at end of Year |
Concept (Decimal) |
As Of |
|
ifrs-full:NumberOfOutstandingShareOptions |
650 |
Exercise price range |
Concept (Monetary) |
As Of |
|
ifrs-full:ExercisePriceOfOutstandingShareOptions |
651 |
Weighted average of remaining useful life |
Concept (Decimal) |
As Of |
|
ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions |
652 |
41704 - Disclosure - SHARE-BASED PAYMENTS - Expenses Recognized in Profit or Loss (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureShareBasedPaymentsExpensesRecognizedInProfitOrLossDetails |
653 |
Implied Table |
Table |
* |
* |
implied:Table |
654 |
SHARE-BASED PAYMENTS |
Abstract |
|
|
ifrs-full:DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementAbstract |
655 |
Expenses recognized in profit or loss |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets |
656 |
Unrecognized compensation expenses |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:LiabilitiesFromSharebasedPaymentTransactions2011 |
657 |
41801 - Disclosure - NET REVENUES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureNetRevenuesDetails |
658 |
Implied Table |
Table |
* |
* |
implied:Table |
659 |
NET REVENUES |
Abstract |
|
|
ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersAbstract |
660 |
Revenues |
Abstract |
|
|
ifrs-full:RevenueAbstract |
661 |
Licensing |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:LicenceFeeIncome |
662 |
Commercialization of product |
Concept (Monetary) |
For Period |
Credit |
rdhl:CommercializationRevenue |
663 |
Promotional services |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:RevenueFromRenderingOfAdvertisingServices |
664 |
Other Revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherRevenue |
665 |
Total Net Revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
666 |
41901 - Disclosure - RESEARCH AND DEVELOPMENT EXPENSES, net (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureResearchAndDevelopmentExpensesNetDetails |
667 |
Research And Development Expenses Net [Table] |
Table |
* |
* |
rdhl:ResearchAndDevelopmentExpensesNetTable |
668 |
IFRS Income Statement Location [Axis] |
Axis |
|
|
rdhl:IfrsIncomeStatementLocationAxis |
669 |
IFRS Income Statement Location [Domain] |
Member |
|
|
rdhl:IfrsIncomeStatementLocationDomain |
670 |
Payroll and related expenses |
Member |
|
|
rdhl:PayrollAndRelatedExpenseMember |
671 |
Professional services |
Member |
|
|
rdhl:ProfessionalServicesExpenseMember |
672 |
Share-based payments |
Member |
|
|
rdhl:ExpenseFromSharebasedPaymentTransactionsMember |
673 |
Clinical and pre-clinical trials |
Member |
|
|
rdhl:ClinicalAndPreClinicalTrialsExpenseMember |
674 |
Intellectual property development |
Member |
|
|
rdhl:IntellectualPropertyDevelopmentExpenseMember |
675 |
Other |
Member |
|
|
rdhl:OtherResearchAndDevelopmentExpenseMember |
676 |
Research And Development Expenses Net [Line Items] |
LineItems |
|
|
rdhl:ResearchAndDevelopmentExpensesNetLineItems |
677 |
Research and development expenses, gross |
Concept (Monetary) |
For Period |
Debit |
rdhl:ResearchAndDevelopmentExpenseGross |
678 |
Research and development expenses, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
679 |
42001 - Disclosure - SELLING, MARKETING AND BUSINESS DEVELOPMENT EXPENSES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSellingMarketingAndBusinessDevelopmentExpensesDetails |
680 |
Selling Marketing And Business Development Expenses [Table] |
Table |
* |
* |
rdhl:SellingMarketingAndBusinessDevelopmentExpensesTable |
681 |
IFRS Income Statement Location [Axis] |
Axis |
|
|
rdhl:IfrsIncomeStatementLocationAxis |
682 |
IFRS Income Statement Location [Domain] |
Member |
|
|
rdhl:IfrsIncomeStatementLocationDomain |
683 |
Payroll and related expenses |
Member |
|
|
rdhl:PayrollAndRelatedExpenseMember |
684 |
Share-based payments |
Member |
|
|
rdhl:ExpenseFromSharebasedPaymentTransactionsMember |
685 |
Professional services |
Member |
|
|
rdhl:ProfessionalServicesExpenseMember |
686 |
Samples |
Member |
|
|
rdhl:PromotionalSamplesExpenseMember |
687 |
Travel and related expenses |
Member |
|
|
rdhl:TravelAndRelatedExpenseMember |
688 |
Office related expenses, net |
Member |
|
|
rdhl:OfficeRelatedExpensesNetMember |
689 |
Other |
Member |
|
|
rdhl:OtherResearchAndDevelopmentExpenseMember |
690 |
Selling Marketing And Business Development Expenses [Line Items] |
LineItems |
|
|
rdhl:SellingMarketingAndBusinessDevelopmentExpensesLineItems |
691 |
Selling, marketing and business development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SalesAndMarketingExpense |
692 |
42101 - Disclosure - GENERAL AND ADMINISTRATIVE EXPENSES (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureGeneralAndAdministrativeExpensesDetails |
693 |
General And Administrative Expense [Table] |
Table |
* |
* |
rdhl:GeneralAndAdministrativeExpenseTable |
694 |
IFRS Income Statement Location [Axis] |
Axis |
|
|
rdhl:IfrsIncomeStatementLocationAxis |
695 |
IFRS Income Statement Location [Domain] |
Member |
|
|
rdhl:IfrsIncomeStatementLocationDomain |
696 |
Payroll and related expenses |
Member |
|
|
rdhl:PayrollAndRelatedExpenseMember |
697 |
Share-based payments |
Member |
|
|
rdhl:ExpenseFromSharebasedPaymentTransactionsMember |
698 |
Professional services |
Member |
|
|
rdhl:ProfessionalServicesExpenseMember |
699 |
Office related expenses, net |
Member |
|
|
rdhl:OfficeRelatedExpensesNetMember |
700 |
Other |
Member |
|
|
rdhl:OtherResearchAndDevelopmentExpenseMember |
701 |
General And Administrative Expense [Line Items] |
LineItems |
|
|
rdhl:GeneralAndAdministrativeExpenseLineItems |
702 |
General and administrative expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
703 |
42201 - Disclosure - FINANCIAL INCOME, net (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureFinancialIncomeNetDetails |
704 |
Implied Table |
Table |
* |
* |
implied:Table |
705 |
FINANCIAL INCOME, net |
Abstract |
|
|
rdhl:FinanceExpensesIncomeNetAbstract |
706 |
Fair value gain on derivative financial instruments |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities |
707 |
Gains on financial assets at fair value through profit or loss |
Concept (Monetary) |
For Period |
|
ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementAssets |
708 |
Gain from changes in exchange rates |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesRegulatoryDeferralAccountCreditBalances |
709 |
Interest from bank deposits |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:InterestIncomeOnDeposits |
710 |
Financial income |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncome |
711 |
Loss from changes in exchange rates |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:IncreaseDecreaseThroughChangesInForeignExchangeRatesRegulatoryDeferralAccountDebitBalances |
712 |
Issuance cost with respect of warrants |
Concept (Monetary) |
For Period |
Debit |
rdhl:AdjustmentsIssuedCostInRespectOfWarrants |
713 |
Other |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:OtherFinanceCost |
714 |
Financial expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:FinanceCosts |
715 |
Financial income net |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:FinanceIncomeCost |
716 |
42301 - Disclosure - SEGMENT INFORMATION (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSegmentInformationDetails |
717 |
Disclosure of operating segments [table] |
Table |
* |
* |
ifrs-full:DisclosureOfOperatingSegmentsTable |
718 |
Segments [axis] |
Axis |
|
|
ifrs-full:SegmentsAxis |
719 |
Segments [member] |
Member |
|
|
ifrs-full:SegmentsMember |
720 |
Reportable segments [member] |
Member |
|
|
ifrs-full:ReportableSegmentsMember |
721 |
Commercial Operation |
Member |
|
|
rdhl:CommercialOperationMember |
722 |
Research and Development |
Member |
|
|
rdhl:ResearchAndDevelopmentMember |
723 |
Disclosure of operating segments [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfOperatingSegmentsLineItems |
724 |
Net revenues |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:Revenue |
725 |
Cost of revenues |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:CostOfSales |
726 |
Gross profit |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:GrossProfit |
727 |
Research and development expenses, net |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:ResearchAndDevelopmentExpense |
728 |
Selling, marketing and business development expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SalesAndMarketingExpense |
729 |
General and administrative expenses |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:SellingGeneralAndAdministrativeExpense |
730 |
Other expenses |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:OtherOperatingIncomeExpense |
731 |
Operating loss |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossFromOperatingActivities |
732 |
42302 - Disclosure - SEGMENT INFORMATION - Major Customers (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureSegmentInformationMajorCustomersDetails |
733 |
Disclosure of major customers [table] |
Table |
* |
* |
ifrs-full:DisclosureOfMajorCustomersTable |
734 |
Major customers [axis] |
Axis |
|
|
ifrs-full:MajorCustomersAxis |
735 |
Customers [member] |
Member |
|
|
ifrs-full:MajorCustomersMember |
736 |
Customer One |
Member |
|
|
rdhl:CustomerOneMember |
737 |
Customer Two |
Member |
|
|
rdhl:CustomerTwoMember |
738 |
Range [axis] |
Axis |
|
|
ifrs-full:RangeAxis |
739 |
Ranges [member] |
Member |
|
|
ifrs-full:RangesMember |
740 |
Minimum |
Member |
|
|
ifrs-full:BottomOfRangeMember |
741 |
Maximum |
Member |
|
|
ifrs-full:TopOfRangeMember |
742 |
Disclosure of major customers [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfMajorCustomersLineItems |
743 |
Percentage of revenue |
Concept (Percent) |
For Period |
|
ifrs-full:PercentageOfEntitysRevenue |
744 |
Payment terms for customers |
Concept (xbrli:durationItemType) |
For Period |
|
rdhl:PaymentTermsForCustomers |
745 |
42401 - Disclosure - LOSS PER ORDINARY SHARE - Basic (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLossPerOrdinaryShareBasicDetails |
746 |
Implied Table |
Table |
* |
* |
implied:Table |
747 |
LOSS PER ORDINARY SHARE |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
748 |
Basic |
Abstract |
|
|
ifrs-full:BasicEarningsPerShareAbstract |
749 |
Loss (U.S. dollars in thousands) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity |
750 |
Weighted average number of ordinary shares outstanding during the period (in thousands) |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
751 |
Basic loss per share (U.S. dollars) |
Concept (Share) |
For Period |
|
ifrs-full:BasicEarningsLossPerShare |
752 |
42402 - Disclosure - LOSS PER ORDINARY SHARE - Diluted (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureLossPerOrdinaryShareDilutedDetails |
753 |
Implied Table |
Table |
* |
* |
implied:Table |
754 |
LOSS PER ORDINARY SHARE |
Abstract |
|
|
ifrs-full:EarningsPerShareAbstract |
755 |
Diluted |
Abstract |
|
|
ifrs-full:DilutedEarningsPerShareAbstract |
756 |
Loss (U.S. dollars in thousands) |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity |
757 |
Adjustment for financial income of warrants |
Concept (Monetary) |
For Period |
Credit |
rdhl:ProfitLossAdjustmentForFinancialIncomeOfWarrants |
758 |
Loss used to determine diluted loss per share |
Concept (Monetary) |
For Period |
Credit |
ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntityIncludingDilutiveEffects |
759 |
Weighted average number of ordinary shares outstanding during the period (in thousands) |
Concept (Shares) |
For Period |
|
ifrs-full:WeightedAverageShares |
760 |
Adjustment for warrants |
Concept (Shares) |
For Period |
|
ifrs-full:DilutiveEffectOfConvertibleInstrumentsOnNumberOfOrdinaryShares |
761 |
Weighted average number of ordinary shares for diluted loss per share (in thousands) |
Concept (Shares) |
For Period |
|
ifrs-full:AdjustedWeightedAverageShares |
762 |
Diluted loss per share (U.S. dollars) |
Concept (Share) |
For Period |
|
ifrs-full:DilutedEarningsLossPerShare |
763 |
42501 - Disclosure - RELATED PARTIES - Key Management Compensation (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureRelatedPartiesKeyManagementCompensationDetails |
764 |
Implied Table |
Table |
* |
* |
implied:Table |
765 |
RELATED PARTIES |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
766 |
Salaries and other short-term employee benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits |
767 |
Post-employment benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationPostemploymentBenefits |
768 |
Share-based payments |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationSharebasedPayment |
769 |
Other long-term benefits |
Concept (Monetary) |
For Period |
Debit |
ifrs-full:KeyManagementPersonnelCompensationOtherLongtermBenefits |
770 |
42502 - Disclosure - RELATED PARTIES - Balances with Related Parties (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureRelatedPartiesBalancesWithRelatedPartiesDetails |
771 |
Implied Table |
Table |
* |
* |
implied:Table |
772 |
RELATED PARTIES |
Abstract |
|
|
ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesAbstract |
773 |
Current liabilities |
Abstract |
|
|
ifrs-full:CurrentLiabilitiesAbstract |
774 |
Credit balance in “accrued expenses and other current liabilities” |
Concept (Monetary) |
As Of |
Credit |
rdhl:CurrentLiabilitiesRelatedPartyTransactions |
775 |
Non-current liabilities |
Abstract |
|
|
ifrs-full:NoncurrentLiabilitiesAbstract |
776 |
Derivative financial instruments |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:AmountsPayableRelatedPartyTransactions |
777 |
42601 - Disclosure - EVENTS SUBSEQUENT TO DECEMBER 31, 2018 (Details) |
Network |
* |
* |
http://www.redhillbio.com/role/DisclosureEventsSubsequentToDecember312018Details |
778 |
Disclosure of non-adjusting events after reporting period [table] |
Table |
* |
* |
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodTable |
779 |
Classes of ordinary shares [axis] |
Axis |
|
|
ifrs-full:ClassesOfOrdinarySharesAxis |
780 |
Ordinary shares [member] |
Member |
|
|
ifrs-full:OrdinarySharesMember |
781 |
American Depository Shares |
Member |
|
|
rdhl:AmericanDepositorySharesMember |
782 |
Types of share-based payment arrangements [axis] |
Axis |
|
|
ifrs-full:TypesOfSharebasedPaymentArrangementsAxis |
783 |
Share-based payment arrangements [member] |
Member |
|
|
ifrs-full:SharebasedPaymentArrangementsMember |
784 |
Stock Options |
Member |
|
|
rdhl:IfrsEmployeeStockOptionMember |
785 |
Non-adjusting events after reporting period [axis] |
Axis |
|
|
ifrs-full:NonadjustingEventsAfterReportingPeriodAxis |
786 |
Non-adjusting events after reporting period [member] |
Member |
|
|
ifrs-full:NonadjustingEventsMember |
787 |
Major ordinary share transactions |
Member |
|
|
ifrs-full:MajorOrdinaryShareTransactionsMember |
788 |
Disclosure of non-adjusting events after reporting period [line items] |
LineItems |
|
|
ifrs-full:DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems |
789 |
Number of ADSs, granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfInstrumentsGrantedInSharebasedPaymentArrangement |
790 |
Number of options, granted |
Concept (Decimal) |
For Period |
|
ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement |
791 |
Estimated fair value of the options on the grant date |
Concept (Monetary) |
As Of |
Credit |
ifrs-full:WeightedAverageFairValueAtMeasurementDateShareOptionsGranted |